Lataa...
Emerging Variants of Castration-Resistant Prostate Cancer
Metastatic castration resistant prostate cancer (CRPC) is associated with substantial clinical, pathologic, and molecular heterogeneity. Most tumors remain driven by androgen receptor (AR) signaling, which has clinical implications for patient selection for AR-directed approaches. However, histologi...
Tallennettuna:
| Julkaisussa: | Curr Oncol Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479409/ https://ncbi.nlm.nih.gov/pubmed/28361223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0593-6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|